ESC 365 - Lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers: con.

ESC Professional Premium Access

Lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers: con.

Session: Great Debate: lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers

Topic: Cardiovascular Pharmacotherapy

Speaker: Professor C. Baigent (Oxford, GB)

Event: ESC Congress 2022

Congress Presentation

About the speaker

Professor Colin Baigent

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

11 presentations

1 follower

2 more presentations in this session

Lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers: pro.

Speaker: Professor S. Nicholls (Melbourne, AU)

Lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers – the final word.

Access the full session

Great Debate: lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers

Speakers: Professor C. Baigent, Professor S. Nicholls

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by